Advertisement

Advertisement

FBRX Stock Latest News

Why Is Forte Biosciences (FBRX) Stock Up Today?

Market NewsWhy Is Forte Biosciences (FBRX) Stock Up Today?

First Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright

PremiumThe Fly

First Tracks Biotherapeutics price target raised to $44 from $30 at H.C. Wainwright

2d ago

Midday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’

PremiumThe Fly

Midday Fly By: PepsiCo reports mixed Q2, Levi Strauss posts ‘beat and raise’

3d ago

Forte Biosciences trading resumes

PremiumThe Fly

Forte Biosciences trading resumes

3d ago

Forte Biosciences trading halted, volatility trading pause

PremiumThe Fly

Forte Biosciences trading halted, volatility trading pause

3d ago

Forte Biosciences Reports Positive Phase 1b Vitiligo Results

PremiumCompany AnnouncementsForte Biosciences Reports Positive Phase 1b Vitiligo Results

3d ago

Forte Biosciences’ FB102 shows efficacy in vitiligo Phase 1b study

The Fly

Forte Biosciences’ FB102 shows efficacy in vitiligo Phase 1b study

3d ago

Forte Biosciences Shareholders Approve Directors and Governance Items

Company Announcements

Forte Biosciences Shareholders Approve Directors and Governance Items

1M ago

Forte Biosciences: Buy Rating Backed by FB102 Pipeline Momentum and Multiple Upcoming Clinical Catalysts

PremiumRatings

Forte Biosciences: Buy Rating Backed by FB102 Pipeline Momentum and Multiple Upcoming Clinical Catalysts

2M ago

Forte Biosciences reports Q1 EPS ($1.24), consensus ($1.16)

PremiumThe Fly

Forte Biosciences reports Q1 EPS ($1.24), consensus ($1.16)

2M ago

Forte Biosciences Prices $150 Million Public Offering

PremiumCompany Announcements

Forte Biosciences Prices $150 Million Public Offering

3M ago

Forte Biosciences 5.71M share Spot Secondary priced at $26.27

PremiumThe Fly

Forte Biosciences 5.71M share Spot Secondary priced at $26.27

3M ago

Forte Biosciences announces common stock offering, no amount given

PremiumThe FlyForte Biosciences announces common stock offering, no amount given

3M ago

Forte Biosciences reports FY25 EPS ($4.71) vs. ($12.17) last year

The Fly

Forte Biosciences reports FY25 EPS ($4.71) vs. ($12.17) last year

3M ago

Is FBRX a Buy, Before Earnings?

Pre-Earnings

Is FBRX a Buy, Before Earnings?

4M ago

Forte Biosciences initiated with an Outperform at Evercore ISI

PremiumThe Fly

Forte Biosciences initiated with an Outperform at Evercore ISI

8M ago

Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress

PremiumCompany Announcements

Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress

8M ago

Forte Biosciences reports Q3 EPS (99c), consensus ($1.07)

PremiumThe Fly

Forte Biosciences reports Q3 EPS (99c), consensus ($1.07)

8M ago

Forte Biosciences Inc. Launches Promising Study on Alopecia Areata Treatment

PremiumCompany Announcements

Forte Biosciences Inc. Launches Promising Study on Alopecia Areata Treatment

9M ago

Forte Biosciences Advances Celiac Disease Treatment with FB102 Study

PremiumCompany AnnouncementsForte Biosciences Advances Celiac Disease Treatment with FB102 Study

9M ago

Forte Biosciences’ FB102 Study: A Potential Breakthrough in Vitiligo Treatment

Company Announcements

Forte Biosciences’ FB102 Study: A Potential Breakthrough in Vitiligo Treatment

9M ago

Forte Biosciences Reports Q2 2025 Financial Results

Company Announcements

Forte Biosciences Reports Q2 2025 Financial Results

11M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >